Get the Stockscreener App
24.70
0.57%
0.14
After Hours:
24.70
Anika Therapeutics Inc stock is traded at $24.70, with a volume of 22,553.
It is up +0.57% in the last 24 hours and down -3.89% over the past month.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.
See More
Previous Close:
$24.56
Open:
$24.56
24h Volume:
22,553
Relative Volume:
0.46
Market Cap:
$367.15M
Revenue:
$166.88M
Net Income/Loss:
$-74.18M
P/E Ratio:
-16.14
EPS:
-1.53
Net Cash Flow:
$1.14M
1W Performance:
-1.28%
1M Performance:
-3.89%
6M Performance:
-2.76%
1Y Performance:
+32.58%
1-Day Range:
$24.56
$24.98
1-Week Range:
$24.36
$25.04
52-Week Range:
$17.88
$29.11
Anika Therapeutics Inc Stock (ANIK) Company Profile
Name
Anika Therapeutics Inc
Sector
Phone
(781) 457-9000
Address
32 WIGGINS AVENUE, BEDFORD, MA
Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-07-23 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Nov-09-22 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-14-22 | Resumed | Stephens | Equal-Weight |
| Mar-09-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Mar-09-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Nov-16-21 | Initiated | Stephens | Overweight |
| Jul-16-21 | Initiated | UBS | Neutral |
| Dec-16-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-08-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jan-21-20 | Upgrade | Sidoti | Neutral → Buy |
| Jan-10-20 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Nov-05-19 | Initiated | BWS Financial | Sell |
| Sep-24-19 | Reiterated | Barrington Research | Outperform |
| Sep-23-19 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| Jul-25-19 | Upgrade | First Analysis Sec | Neutral → Strong Buy |
| Feb-22-19 | Downgrade | First Analysis Sec | Outperform → Neutral |
| Feb-22-19 | Downgrade | Sidoti | Buy → Neutral |
| Jul-27-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Jun-20-18 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jun-20-18 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| May-04-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Feb-23-18 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jan-24-18 | Upgrade | First Analysis Sec | Equal-Weight → Overweight |
| Oct-27-17 | Reiterated | Barrington Research | Outperform |
| May-09-16 | Upgrade | Singular Research | BUY - Long-Term → Buy |
| Apr-27-16 | Downgrade | Northland Capital | Outperform → Market Perform |
| Feb-26-16 | Reiterated | Barrington Research | Outperform |
View All
Anika Therapeutics Inc Stock (ANIK) Latest News
Meros Investment Management LP Acquires 42,587 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - MarketBeat
Knee Cartilage Repair Market Set for Rapid Growth and Trend - openPR
Facial Injections Market Detailed In Recent Development to Grow - openPR
ProShare Advisors LLC Sells 10,021 Shares of ANSYS, Inc. (NASDAQ:ANSS) - Defense World
Summit Trail Advisors LLC Grows Stock Holdings in ANSYS, Inc. (NASDAQ:ANSS) - Defense World
Profund Advisors LLC Purchases 48 Shares of ANSYS, Inc. (NASDAQ:ANSS) - Defense World
Kayne Anderson Rudnick Investment Management LLC Reduces Stock Position in ANSYS, Inc. (NASDAQ:ANSS) - Defense World
Innate Pharma Advances Novel Cancer Treatment - TipRanks
Stocks of the Hour: Amplia Therapeutics, Wellard, Anax Metals - ShareCafe
Pacer Advisors Inc. Sells 2,311 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Skandinaviska Enskilda Banken AB publ Grows Position in ANSYS, Inc. (NASDAQ:ANSS) - Defense World
Renaissance Technologies LLC Sells 4,875 Shares of ANSYS, Inc. (NASDAQ:ANSS) - Defense World
Renaissance Technologies LLC Grows Stock Holdings in Anika Therapeutics, Inc. (NASDAQ:ANIK) - MarketBeat
ANSYS, Inc. (NASDAQ:ANSS) Shares Sold by Schwerin Boyle Capital Management Inc. - MarketBeat
ANSYS (NASDAQ:ANSS) Research Coverage Started at StockNews.com - MarketBeat
ImmunityBio: Anktiva Launch, Good Data, Low Cash, High Debt (NASDAQ:IBRX) - Seeking Alpha
Sei Investments Co. Has $136.28 Million Stock Holdings in ANSYS, Inc. (NASDAQ:ANSS) - Defense World
ANSYS, Inc. (NASDAQ:ANSS) Shares Sold by King Luther Capital Management Corp - Defense World
Meiji Yasuda Asset Management Co Ltd. Has $465,000 Position in ANSYS, Inc. (NASDAQ:ANSS) - Defense World
Insider Selling: Hoffman William, Inari Medical Inc [NARI] Director divested 40,000 shares - Knox Daily
1,421 Shares in ANSYS, Inc. (NASDAQ:ANSS) Acquired by MQS Management LLC - Defense World
ANSYS, Inc. (NASDAQ:ANSS) Shares Sold by Massachusetts Financial Services Co. MA - Defense World
Inspire Investing LLC Boosts Holdings in ANSYS, Inc. (NASDAQ:ANSS) - Defense World
Is ANSYS Stock Underperforming The Nasdaq? - Barchart
ANSYS, Inc. (NASDAQ:ANSS) Shares Bought by E Fund Management Co. Ltd. - Defense World
Acadian Asset Management LLC Buys Shares of 1,851 ANSYS, Inc. (NASDAQ:ANSS) - Defense World
CCLA Investment Management Buys 4,200 Shares of ANSYS, Inc. (NASDAQ:ANSS) - MarketBeat
When (ANIK) Moves Investors should Listen - Stock Traders Daily
Los Angeles Capital Management LLC Cuts Stock Position in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Anika Therapeutics, Inc. (NASDAQ:ANIK) Stock Position Raised by Acadian Asset Management LLC - MarketBeat
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - StockTitan
Anika Therapeutics (NASDAQ:ANIK) Stock Price Passes Above Two Hundred Day Moving Average of $25.90 - MarketBeat
Objective long/short (ANIK) Report - Stock Traders Daily
Orthopedic Regenerative Surgical Products Market Report - openPR
Anika Therapeutics, Inc. (NASDAQ:ANIK) Stake Reduced by California State Teachers Retirement System - Defense World
Anika Therapeutics, Inc. (NASDAQ:ANIK) Short Interest Update - MarketBeat
Anika Therapeutics, Inc. (NASDAQ:ANIK) Short Interest Down 6.0% in July - Defense World
SIGA: 3 Small-Cap Healthcare Stocks With Breakthrough Potential - StockNews.com
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q2 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Anika reports Q2 2024 earnings, focuses on strategic growth By Investing.com - Investing.com Australia
Earnings call: Anika reports Q2 2024 earnings, focuses on strategic growth By Investing.com - Investing.com UK
Vanguard Group Inc. Grows Stock Position in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Barrington Research Reaffirms Outperform Rating for Anika Therapeutics (NASDAQ:ANIK) - Defense World
Anika Therapeutics (NASDAQ:ANIK) Releases Earnings Results, Misses Expectations By $0.24 EPS - Defense World
Anika Therapeutics, Inc (ANIK) Q2 2024 Earnings Call Transcript - Seeking Alpha
Anika Therapeutics (NASDAQ:ANIK) Announces Quarterly Earnings Results, Misses Expectations By $0.24 EPS - MarketBeat
Anika Therapeutics Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line - Simply Wall St
Anika Therapeutics, Inc. (NASDAQ:ANIK) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates - Yahoo Finance
Anika Therapeutics' (ANIK) Outperform Rating Reaffirmed at Barrington Research - MarketBeat
Anika Therapeutics, Inc. (ANIK): Are Hedge Funds Bullish on This Caligan Partners-Approved Stock? - Yahoo Finance
Anika Therapeutics Inc Stock (ANIK) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.23%
0.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):